Two new Independent Directors at Image Plus

The Board of Directors of Image Plus Consultants Limited is announcing the appointment of Radcliffe Daley and Claude Duncan as Independent Directors on the Board, effective March 23, 2026.

Daley is the current President & CEO of First Global Bank Limited, a subsidiary of the Grace Kennedy Group, while Duncan’s most recent employment was as Country Manager (AVP) for Sutherland Global Services. Daley is an accomplished financial services executive and Corporate Director with over three decades of experience in banking, audit and operations.

Duncan currently advises organisations on transforming customer experience, optimising sales processes, and driving strategic growth. Both gentlemen bring to Image Plus significant years of experience in executive management, finance, operations, accounting, marketing, technology and customer experience.

MDS appoints Duke Holness Non-Executive Independent Director

Medical Disposables & Supplies Limited (MDS) is advising that Duke Holness has been appointed as a Non-Executive Independent Director of the Board of Directors, effective February 4, 2025. He has also been appointed as a member of the Audit and Compliance Committee and the Compensation and Human Resources Committee.

Holness brings to the Board over two decades of senior leadership experience in the pharmaceutical and healthcare sectors, with a distinguished career that includes serving as an executive at GlaxoSmithKline (GSK). During his tenure at GSK, he held key roles across commercial strategy, market development, and operations—providing oversight across multiple Caribbean markets. His strategic insight, strong regulatory appreciation, and deep understanding of pharmaceutical distribution dynamics have contributed to substantial business growth and stakeholder value throughout his career.

Currently, Holness serves as a consultant to regional and international healthcare organisations, advising on commercial optimisation, market entry strategies, and organisational development. His proven ability to navigate complex industry environments, coupled with his strong leadership and analytical capabilities, makes him an invaluable asset to MDS.

The Board is confident that Holness’ extensive experience, industry knowledge, and strategic acumen will further strengthen MDS’ governance framework and support the company’s continued growth within the pharmaceutical, medical supplies, and FMCG distribution landscape.

Dr Marjorie Fyffe-Campbell onboarded at Sagicor X-Fund

Sagicor Real Estate X Fund Limited has announced that Dr Marjorie Fyffe-Campbell has been appointed as a new Director. The appointment was made effective July 31, 2025, but is just being announced.